Case Managers - Advocates - Healthcare Professionals
Learn about available patient assistance programs that may help uninsured individuals living with HIV/AIDS obtain their full regimen of brand-name medications. There is one application for all programs, and you can access HarborPath anytime for up-to-the-minute status about an individual's application or drug delivery date.
Patients
Are you uninsured and living with HIV/AIDS and need help affording your medications? Speak with your healthcare professional or case manager about available patient assistance programs. Through HarborPath, your healthcare team can access the simple application form and apply on your behalf for free medications.
@harborpath
HarborPath: @harborpath
RT @CareXOinfo: #Twitter Now a Tool for Reducing HIV Outbreaks #HIV @twitter http://t.co/nYNdhK0SPi 3 days ago
RT @CareXOinfo: #Twitter Now a Tool for Reducing HIV Outbreaks #HIV @twitter http://t.co/nYNdhK0SPi 3 days ago
HarborPath: @harborpath
Studies show big promise for #HIV prevention shot - Washington Times: http://t.co/grIwmL4ge9 via @washtimes 4 days ago
Studies show big promise for #HIV prevention shot - Washington Times: http://t.co/grIwmL4ge9 via @washtimes 4 days ago
HarborPath: @harborpath
RT @SamBrownInc: -> 60,000 With #HIV Left Uninsured In States Not Expanding Medicaid. http://t.co/SaFo0c6aUD 5 days ago
RT @SamBrownInc: -> 60,000 With #HIV Left Uninsured In States Not Expanding Medicaid. http://t.co/SaFo0c6aUD 5 days ago
About HarborPath
HarborPath is a non-profit organization dedicated to helping the uninsured living with HIV/AIDS and/or Hepatitis C gain access to free medications offered by Patient Assistance Programs (PAPs) by creating a single place for application and medication fulfillment. This "one stop shop" portal provides a streamlined, online process to qualify individuals and deliver the donated medications of the participating pharmaceutical companies through a mail-order pharmacy.Our Sponsors
AbbVie joins Bristol-Myers Squibb, Gilead, Merck and ViiV Healthcare as the fifth pharmaceutical company to support HarborPath since its launch in July 2012.
